🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Iowa › Cedar Rapids

Etid klinik pou Kansè (tout kalite) nan Cedar Rapids, IA

15 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Cedar Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • University of Iowa Health, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Ap rekriteEtid obsèvasyon
  • The State University of Iowa, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • University of Iowa Hospitals ( Site 4017), Iowa City · 25 mi lwen
1 Month – 17 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT07630974

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Ap rekriteFaz 3
  • Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06901531

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • University of Iowa Health Care Holden Comprehensive Cancer Center ( Site 3017), Iowa City · 25 mi lwen
1 Month – 17 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06941272

Collection of Tissue Samples for Cancer Research

Ap rekriteEtid obsèvasyon
  • University of Iowa, Iowa City · 25 mi lwen
2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

Lurbinectedin in FET-Fused Tumors

Ap rekriteFaz 1/2
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi lwen
Laj 10 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05918640

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Ap rekriteFaz 1
  • University of Iowa Hospitals, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT05719558

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of Iowa, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

Molecular Genetics Studies of Cancer Patients and Their Relatives

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mercy Hospital, Cedar Rapids
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT04185935

GEMINI-NSCLC: NSCLC Biomarker Study

Ap rekriteEtid obsèvasyon
  • University of Iowa, Iowa City · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

Beat Childhood Cancer Specimen Banking and Data Registry

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of Iowa, Iowa City · 25 mi lwen
Tout laj · Tout sèks · Mizajou Feb 3, 2026 · NCT04715178

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Iowa City · 25 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Cedar Rapids

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.